[go: up one dir, main page]

CU20160026A7 - FORMULATION OF DELAYED RELEASE DRUG - Google Patents

FORMULATION OF DELAYED RELEASE DRUG

Info

Publication number
CU20160026A7
CU20160026A7 CUP2016000026A CU20160026A CU20160026A7 CU 20160026 A7 CU20160026 A7 CU 20160026A7 CU P2016000026 A CUP2016000026 A CU P2016000026A CU 20160026 A CU20160026 A CU 20160026A CU 20160026 A7 CU20160026 A7 CU 20160026A7
Authority
CU
Cuba
Prior art keywords
delayed release
drug
core
inner layer
formulation
Prior art date
Application number
CUP2016000026A
Other languages
Spanish (es)
Other versions
CU24343B1 (en
Inventor
González Roberto Carlos Bravo
Thomas Buser
Frédéric Jean-Claude Goutte
Abdul Waseh Basit
Felipe José Oliveria Varum
Ana Cristina Freire
Original Assignee
Tillotts Pharma Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from EP12166110.2A external-priority patent/EP2659881B1/en
Application filed by Tillotts Pharma Ag filed Critical Tillotts Pharma Ag
Publication of CU20160026A7 publication Critical patent/CU20160026A7/en
Publication of CU24343B1 publication Critical patent/CU24343B1/en

Links

Landscapes

  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

La liberación retardada de un fármaco al colon se logra de una formulación de liberación retardada que comprende un núcleo y un recubrimiento para el núcleo. El núcleo comprende un fármaco y un recubrimiento que comprende una capa interior y una capa exterior. La capa interior comprende un tercer material polimérico que es soluble en el fluido intestinal o en el fluido gastrointestinal, el tercer material polimérico es un polímero no iónico, la capa interior comprende al menos un agente amortiguador y una base. Las ventajas de las formulaciones de acuerdo con la presente invención incluyen la liberación acelerada del fármaco cuando se expone a condiciones colónicas y la reducción o eliminación del efecto de los alimentos y/o alcohol en la liberación del fármaco después de la administración.Delayed release of a drug to the colon is achieved from a delayed release formulation comprising a core and a coating for the core. The core comprises a drug and a coating comprising an inner layer and an outer layer. The inner layer comprises a third polymeric material that is soluble in the intestinal fluid or in the gastrointestinal fluid, the third polymeric material is a non-ionic polymer, the inner layer comprises at least one buffering agent and a base. Advantages of the formulations according to the present invention include accelerated drug release when exposed to colonic conditions and the reduction or elimination of the effect of food and / or alcohol on drug release after administration.

CUP2016000026A 2012-04-30 2013-04-29 FORMULATION OF DELAYED RELEASE DRUG CU24343B1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201261640217P 2012-04-30 2012-04-30
EP12166110.2A EP2659881B1 (en) 2012-04-30 2012-04-30 A delayed release drug formulation
PCT/EP2013/058921 WO2013164315A1 (en) 2012-04-30 2013-04-29 A delayed release drug formulation

Publications (2)

Publication Number Publication Date
CU20160026A7 true CU20160026A7 (en) 2016-05-30
CU24343B1 CU24343B1 (en) 2018-05-08

Family

ID=54196716

Family Applications (2)

Application Number Title Priority Date Filing Date
CUP2016000014A CU24342B1 (en) 2012-04-30 2013-04-29 FORMULATION OF DELAYED RELEASE DRUG
CUP2016000026A CU24343B1 (en) 2012-04-30 2013-04-29 FORMULATION OF DELAYED RELEASE DRUG

Family Applications Before (1)

Application Number Title Priority Date Filing Date
CUP2016000014A CU24342B1 (en) 2012-04-30 2013-04-29 FORMULATION OF DELAYED RELEASE DRUG

Country Status (10)

Country Link
JP (2) JP6626470B2 (en)
CL (2) CL2017001989A1 (en)
CU (2) CU24342B1 (en)
CY (1) CY1121470T1 (en)
EC (2) ECSP14028079A (en)
HK (1) HK1244435B (en)
HR (3) HRP20192210T1 (en)
IL (2) IL235283A (en)
PH (3) PH12017502369A1 (en)
ZA (1) ZA201407675B (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2994844T3 (en) * 2018-12-07 2025-02-03 Tillotts Pharma Ag Colonic drug delivery formulation
EP3662900A1 (en) * 2018-12-07 2020-06-10 Tillotts Pharma AG Colonic drug delivery formulation
ES3002632T3 (en) 2018-12-07 2025-03-07 Tillotts Pharma Ag Delayed release drug formulation comprising an outerlayer with an enzymatically degradable polymer, its composition and its method of manufacturing
CN113493220A (en) * 2020-04-02 2021-10-12 杨洋 Hollow metal oxide microsphere, preparation method thereof and drug sustained-release application

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5422121A (en) * 1990-11-14 1995-06-06 Rohm Gmbh Oral dosage unit form
JP5167345B2 (en) * 2007-05-07 2013-03-21 エボニック レーム ゲゼルシャフト ミット ベシュレンクテル ハフツング Solid dosage form with enteric coating for accelerated drug release
HUE036187T2 (en) * 2012-04-30 2018-06-28 Tillotts Pharma Ag A delayed release drug formulation

Also Published As

Publication number Publication date
CU24343B1 (en) 2018-05-08
JP6700220B2 (en) 2020-05-27
HRP20192210T1 (en) 2020-02-21
IL235283A (en) 2017-09-28
CY1121470T1 (en) 2020-05-29
JP6626470B2 (en) 2019-12-25
CU20160014A7 (en) 2016-04-25
ECSP14028077A (en) 2015-12-31
CU24342B1 (en) 2018-05-08
ECSP14028079A (en) 2015-12-31
JP2017145268A (en) 2017-08-24
CL2017001990A1 (en) 2018-03-16
HK1202266A1 (en) 2015-09-25
CL2017001989A1 (en) 2018-03-16
HK1244435B (en) 2019-10-25
HRP20190470T1 (en) 2019-05-17
PH12018501311A1 (en) 2020-09-14
ZA201407675B (en) 2016-05-25
PH12018500304A1 (en) 2018-09-24
HK1202267A1 (en) 2015-09-25
PH12018500304B1 (en) 2018-09-24
IL235282A (en) 2017-09-28
PH12017502369A1 (en) 2020-09-28
JP2017145267A (en) 2017-08-24
HRP20190727T1 (en) 2019-06-14

Similar Documents

Publication Publication Date Title
CO7141433A2 (en) Delayed Release Drug Formulation
MX2018014906A (en) NASAL PHARMACEUTICAL COMPOSITIONS WITH A POROUS EXCIPIENT.
MX2019002162A (en) DELAYED RELEASE DRUG FORMULATION.
CU20160026A7 (en) FORMULATION OF DELAYED RELEASE DRUG
CR20180030A (en) SOLID PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF HCV.
CL2018000138A1 (en) Solid pharmaceutical composition comprising compound 1 and compound 2 in solid amorphous dispersions, and their dissolution profiles.
CU20140124A7 (en) FORMULATION OF DELAYED RELEASE DRUG
TH148827A (en) Delayed release formulation